Denosumab Fracture Data Positive In Prostate Cancer Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen’s twice-yearly injection still has high bar to pass on fracture risk reduction in postmenopausal women with osteoporosis.